Characterization and Evaluation of a Folic Acid Receptor-Targeted Norcantharidin/Tetrandrine Dual-Drug Loaded Delivery System

<div>The cell apoptosis after the LO2, HepG2, and HepG2/Adr cells treated with FA-LP@Tet/(MSNs@ NCTD) at concentrations from 0 <i>μ</i>g/mL to 16 <i>μ</i>g/mL for 24 h.</div>

Journal of Nanomaterials

fig15

Figure 15

Figure 15: Characterization and Evaluation of a Folic Acid Receptor-Targeted Norcantharidin/Tetrandrine Dual-Drug Loaded Delivery System 